nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—SLC10A1—Ethinyl Estradiol—osteoporosis	0.143	0.18	CbGbCtD
Pitavastatin—SLC10A1—Conjugated Estrogens—osteoporosis	0.105	0.132	CbGbCtD
Pitavastatin—SLCO2B1—Conjugated Estrogens—osteoporosis	0.0583	0.0735	CbGbCtD
Pitavastatin—SLCO1B3—Conjugated Estrogens—osteoporosis	0.0518	0.0653	CbGbCtD
Pitavastatin—SLCO2B1—Estradiol—osteoporosis	0.0512	0.0646	CbGbCtD
Pitavastatin—SLCO1B3—Estradiol—osteoporosis	0.0455	0.0573	CbGbCtD
Pitavastatin—ABCC2—Ethinyl Estradiol—osteoporosis	0.0361	0.0455	CbGbCtD
Pitavastatin—ALB—Estropipate—osteoporosis	0.0349	0.044	CbGbCtD
Pitavastatin—SLCO1B1—Conjugated Estrogens—osteoporosis	0.0302	0.038	CbGbCtD
Pitavastatin—ABCC2—Conjugated Estrogens—osteoporosis	0.0265	0.0334	CbGbCtD
Pitavastatin—SLCO1B1—Estradiol—osteoporosis	0.0265	0.0334	CbGbCtD
Pitavastatin—ABCG2—Conjugated Estrogens—osteoporosis	0.024	0.0302	CbGbCtD
Pitavastatin—ABCG2—Estradiol—osteoporosis	0.021	0.0265	CbGbCtD
Pitavastatin—CYP2C9—Estropipate—osteoporosis	0.0188	0.0237	CbGbCtD
Pitavastatin—CYP2C8—Raloxifene—osteoporosis	0.018	0.0227	CbGbCtD
Pitavastatin—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0174	0.0219	CbGbCtD
Pitavastatin—ALB—Estradiol—osteoporosis	0.0145	0.0183	CbGbCtD
Pitavastatin—CYP2C8—Cholecalciferol—osteoporosis	0.0139	0.0175	CbGbCtD
Pitavastatin—ABCB1—Ethinyl Estradiol—osteoporosis	0.0118	0.0148	CbGbCtD
Pitavastatin—CYP2C8—Estradiol—osteoporosis	0.0112	0.0141	CbGbCtD
Pitavastatin—CYP2C9—Cholecalciferol—osteoporosis	0.0097	0.0122	CbGbCtD
Pitavastatin—ABCB1—Conjugated Estrogens—osteoporosis	0.00864	0.0109	CbGbCtD
Pitavastatin—CYP2C9—Estradiol—osteoporosis	0.00782	0.00986	CbGbCtD
Pitavastatin—ABCB1—Estradiol—osteoporosis	0.00759	0.00956	CbGbCtD
Pitavastatin—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.000542	0.00407	CcSEcCtD
Pitavastatin—Nausea—Calcium Acetate—osteoporosis	0.000538	0.00404	CcSEcCtD
Pitavastatin—Arthralgia—Estropipate—osteoporosis	0.000537	0.00403	CcSEcCtD
Pitavastatin—Myalgia—Estropipate—osteoporosis	0.000537	0.00403	CcSEcCtD
Pitavastatin—Myalgia—Alendronate—osteoporosis	0.000529	0.00397	CcSEcCtD
Pitavastatin—Dyspepsia—Etidronic acid—osteoporosis	0.000524	0.00393	CcSEcCtD
Pitavastatin—Discomfort—Alendronate—osteoporosis	0.000523	0.00393	CcSEcCtD
Pitavastatin—Myalgia—Raloxifene—osteoporosis	0.00052	0.00391	CcSEcCtD
Pitavastatin—Arthralgia—Raloxifene—osteoporosis	0.00052	0.00391	CcSEcCtD
Pitavastatin—Arthralgia—Ibandronate—osteoporosis	0.000515	0.00387	CcSEcCtD
Pitavastatin—Myalgia—Ibandronate—osteoporosis	0.000515	0.00387	CcSEcCtD
Pitavastatin—Constipation—Etidronic acid—osteoporosis	0.000509	0.00382	CcSEcCtD
Pitavastatin—Discomfort—Ibandronate—osteoporosis	0.000509	0.00382	CcSEcCtD
Pitavastatin—Myalgia—Calcitriol—osteoporosis	0.000504	0.00379	CcSEcCtD
Pitavastatin—Discomfort—Calcitriol—osteoporosis	0.000498	0.00374	CcSEcCtD
Pitavastatin—Nasopharyngitis—Estradiol—osteoporosis	0.000495	0.00372	CcSEcCtD
Pitavastatin—Hypoaesthesia—Zoledronate—osteoporosis	0.000495	0.00372	CcSEcCtD
Pitavastatin—Back pain—Ethinyl Estradiol—osteoporosis	0.000495	0.00371	CcSEcCtD
Pitavastatin—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.000492	0.00369	CcSEcCtD
Pitavastatin—Feeling abnormal—Etidronic acid—osteoporosis	0.00049	0.00368	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000487	0.00365	CcSEcCtD
Pitavastatin—Back pain—Risedronate—osteoporosis	0.000482	0.00362	CcSEcCtD
Pitavastatin—Muscle spasms—Risedronate—osteoporosis	0.000479	0.0036	CcSEcCtD
Pitavastatin—Influenza—Estradiol—osteoporosis	0.000479	0.0036	CcSEcCtD
Pitavastatin—Hypoaesthesia—Conjugated Estrogens—osteoporosis	0.000476	0.00358	CcSEcCtD
Pitavastatin—Nausea—Ergocalciferol—osteoporosis	0.000476	0.00357	CcSEcCtD
Pitavastatin—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.000474	0.00356	CcSEcCtD
Pitavastatin—Urticaria—Etidronic acid—osteoporosis	0.000473	0.00355	CcSEcCtD
Pitavastatin—Abdominal pain—Etidronic acid—osteoporosis	0.00047	0.00353	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000469	0.00352	CcSEcCtD
Pitavastatin—Insomnia—Estropipate—osteoporosis	0.000466	0.0035	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000462	0.00347	CcSEcCtD
Pitavastatin—Malaise—Ethinyl Estradiol—osteoporosis	0.000461	0.00346	CcSEcCtD
Pitavastatin—Abdominal discomfort—Estradiol—osteoporosis	0.000459	0.00345	CcSEcCtD
Pitavastatin—Back pain—Pamidronate—osteoporosis	0.000458	0.00344	CcSEcCtD
Pitavastatin—Muscle spasms—Pamidronate—osteoporosis	0.000456	0.00342	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000454	0.00341	CcSEcCtD
Pitavastatin—Dyspepsia—Estropipate—osteoporosis	0.000453	0.0034	CcSEcCtD
Pitavastatin—Insomnia—Raloxifene—osteoporosis	0.000451	0.00339	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00045	0.00338	CcSEcCtD
Pitavastatin—Insomnia—Ibandronate—osteoporosis	0.000447	0.00335	CcSEcCtD
Pitavastatin—Dyspepsia—Alendronate—osteoporosis	0.000446	0.00335	CcSEcCtD
Pitavastatin—Fatigue—Estropipate—osteoporosis	0.000444	0.00333	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.00044	0.00331	CcSEcCtD
Pitavastatin—Constipation—Estropipate—osteoporosis	0.00044	0.00331	CcSEcCtD
Pitavastatin—Ill-defined disorder—Pamidronate—osteoporosis	0.00044	0.0033	CcSEcCtD
Pitavastatin—Dyspepsia—Raloxifene—osteoporosis	0.000439	0.0033	CcSEcCtD
Pitavastatin—Hypersensitivity—Etidronic acid—osteoporosis	0.000438	0.00329	CcSEcCtD
Pitavastatin—Insomnia—Calcitriol—osteoporosis	0.000437	0.00328	CcSEcCtD
Pitavastatin—Dyspepsia—Ibandronate—osteoporosis	0.000435	0.00326	CcSEcCtD
Pitavastatin—Constipation—Alendronate—osteoporosis	0.000434	0.00326	CcSEcCtD
Pitavastatin—Discomfort—Ethinyl Estradiol—osteoporosis	0.00043	0.00323	CcSEcCtD
Pitavastatin—Malaise—Pamidronate—osteoporosis	0.000427	0.00321	CcSEcCtD
Pitavastatin—Fatigue—Ibandronate—osteoporosis	0.000426	0.0032	CcSEcCtD
Pitavastatin—Arthralgia—Risedronate—osteoporosis	0.000424	0.00319	CcSEcCtD
Pitavastatin—Myalgia—Risedronate—osteoporosis	0.000424	0.00319	CcSEcCtD
Pitavastatin—Constipation—Ibandronate—osteoporosis	0.000422	0.00317	CcSEcCtD
Pitavastatin—Pruritus—Etidronic acid—osteoporosis	0.000421	0.00316	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Estropipate—osteoporosis	0.000421	0.00316	CcSEcCtD
Pitavastatin—Back pain—Zoledronate—osteoporosis	0.000419	0.00314	CcSEcCtD
Pitavastatin—Feeling abnormal—Alendronate—osteoporosis	0.000418	0.00314	CcSEcCtD
Pitavastatin—Muscle spasms—Zoledronate—osteoporosis	0.000416	0.00313	CcSEcCtD
Pitavastatin—Jaundice—Estradiol—osteoporosis	0.000416	0.00313	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Alendronate—osteoporosis	0.000415	0.00311	CcSEcCtD
Pitavastatin—Constipation—Calcitriol—osteoporosis	0.000413	0.0031	CcSEcCtD
Pitavastatin—Urticaria—Estropipate—osteoporosis	0.000409	0.00307	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Raloxifene—osteoporosis	0.000408	0.00306	CcSEcCtD
Pitavastatin—Diarrhoea—Etidronic acid—osteoporosis	0.000407	0.00306	CcSEcCtD
Pitavastatin—Abdominal pain—Estropipate—osteoporosis	0.000407	0.00306	CcSEcCtD
Pitavastatin—Feeling abnormal—Ibandronate—osteoporosis	0.000407	0.00306	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Ibandronate—osteoporosis	0.000404	0.00303	CcSEcCtD
Pitavastatin—Myalgia—Pamidronate—osteoporosis	0.000404	0.00303	CcSEcCtD
Pitavastatin—Arthralgia—Pamidronate—osteoporosis	0.000404	0.00303	CcSEcCtD
Pitavastatin—Back pain—Conjugated Estrogens—osteoporosis	0.000403	0.00303	CcSEcCtD
Pitavastatin—Urticaria—Alendronate—osteoporosis	0.000403	0.00303	CcSEcCtD
Pitavastatin—Ill-defined disorder—Zoledronate—osteoporosis	0.000402	0.00302	CcSEcCtD
Pitavastatin—Abdominal pain—Alendronate—osteoporosis	0.000401	0.00301	CcSEcCtD
Pitavastatin—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000401	0.00301	CcSEcCtD
Pitavastatin—Discomfort—Pamidronate—osteoporosis	0.000399	0.00299	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Calcitriol—osteoporosis	0.000395	0.00297	CcSEcCtD
Pitavastatin—Abdominal pain—Raloxifene—osteoporosis	0.000394	0.00296	CcSEcCtD
Pitavastatin—Urticaria—Ibandronate—osteoporosis	0.000392	0.00295	CcSEcCtD
Pitavastatin—Malaise—Zoledronate—osteoporosis	0.00039	0.00293	CcSEcCtD
Pitavastatin—Abdominal pain—Ibandronate—osteoporosis	0.00039	0.00293	CcSEcCtD
Pitavastatin—Confusional state—Pamidronate—osteoporosis	0.00039	0.00293	CcSEcCtD
Pitavastatin—Urticaria—Calcitriol—osteoporosis	0.000384	0.00288	CcSEcCtD
Pitavastatin—Hepatitis—Estradiol—osteoporosis	0.000383	0.00288	CcSEcCtD
Pitavastatin—Abdominal pain—Calcitriol—osteoporosis	0.000382	0.00287	CcSEcCtD
Pitavastatin—Hypoaesthesia—Estradiol—osteoporosis	0.000381	0.00286	CcSEcCtD
Pitavastatin—Hypersensitivity—Estropipate—osteoporosis	0.000379	0.00285	CcSEcCtD
Pitavastatin—Rash—Etidronic acid—osteoporosis	0.000375	0.00282	CcSEcCtD
Pitavastatin—Dermatitis—Etidronic acid—osteoporosis	0.000375	0.00282	CcSEcCtD
Pitavastatin—Hypersensitivity—Alendronate—osteoporosis	0.000374	0.00281	CcSEcCtD
Pitavastatin—Headache—Etidronic acid—osteoporosis	0.000373	0.0028	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000371	0.00278	CcSEcCtD
Pitavastatin—Asthenia—Estropipate—osteoporosis	0.000369	0.00277	CcSEcCtD
Pitavastatin—Arthralgia—Zoledronate—osteoporosis	0.000369	0.00277	CcSEcCtD
Pitavastatin—Myalgia—Zoledronate—osteoporosis	0.000369	0.00277	CcSEcCtD
Pitavastatin—Insomnia—Risedronate—osteoporosis	0.000368	0.00276	CcSEcCtD
Pitavastatin—Pruritus—Estropipate—osteoporosis	0.000364	0.00274	CcSEcCtD
Pitavastatin—Discomfort—Zoledronate—osteoporosis	0.000364	0.00273	CcSEcCtD
Pitavastatin—Asthenia—Alendronate—osteoporosis	0.000364	0.00273	CcSEcCtD
Pitavastatin—Hypersensitivity—Ibandronate—osteoporosis	0.000364	0.00273	CcSEcCtD
Pitavastatin—Fatigue—Ethinyl Estradiol—osteoporosis	0.00036	0.0027	CcSEcCtD
Pitavastatin—Pruritus—Alendronate—osteoporosis	0.000359	0.00269	CcSEcCtD
Pitavastatin—Dyspepsia—Risedronate—osteoporosis	0.000358	0.00269	CcSEcCtD
Pitavastatin—Constipation—Ethinyl Estradiol—osteoporosis	0.000357	0.00268	CcSEcCtD
Pitavastatin—Confusional state—Zoledronate—osteoporosis	0.000356	0.00268	CcSEcCtD
Pitavastatin—Hypersensitivity—Calcitriol—osteoporosis	0.000356	0.00267	CcSEcCtD
Pitavastatin—Arthralgia—Conjugated Estrogens—osteoporosis	0.000355	0.00267	CcSEcCtD
Pitavastatin—Myalgia—Conjugated Estrogens—osteoporosis	0.000355	0.00267	CcSEcCtD
Pitavastatin—Asthenia—Ibandronate—osteoporosis	0.000354	0.00266	CcSEcCtD
Pitavastatin—Nausea—Etidronic acid—osteoporosis	0.000354	0.00265	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000352	0.00265	CcSEcCtD
Pitavastatin—Diarrhoea—Estropipate—osteoporosis	0.000352	0.00265	CcSEcCtD
Pitavastatin—Fatigue—Risedronate—osteoporosis	0.000351	0.00263	CcSEcCtD
Pitavastatin—Insomnia—Pamidronate—osteoporosis	0.00035	0.00263	CcSEcCtD
Pitavastatin—Pruritus—Ibandronate—osteoporosis	0.000349	0.00262	CcSEcCtD
Pitavastatin—Constipation—Risedronate—osteoporosis	0.000348	0.00261	CcSEcCtD
Pitavastatin—Diarrhoea—Alendronate—osteoporosis	0.000347	0.00261	CcSEcCtD
Pitavastatin—Asthenia—Calcitriol—osteoporosis	0.000347	0.0026	CcSEcCtD
Pitavastatin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000344	0.00258	CcSEcCtD
Pitavastatin—Pruritus—Calcitriol—osteoporosis	0.000342	0.00257	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000341	0.00256	CcSEcCtD
Pitavastatin—Diarrhoea—Raloxifene—osteoporosis	0.000341	0.00256	CcSEcCtD
Pitavastatin—Dyspepsia—Pamidronate—osteoporosis	0.00034	0.00256	CcSEcCtD
Pitavastatin—Dizziness—Estropipate—osteoporosis	0.00034	0.00256	CcSEcCtD
Pitavastatin—Diarrhoea—Ibandronate—osteoporosis	0.000338	0.00254	CcSEcCtD
Pitavastatin—Dizziness—Alendronate—osteoporosis	0.000335	0.00252	CcSEcCtD
Pitavastatin—Fatigue—Pamidronate—osteoporosis	0.000333	0.0025	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Risedronate—osteoporosis	0.000333	0.0025	CcSEcCtD
Pitavastatin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000332	0.00249	CcSEcCtD
Pitavastatin—Constipation—Pamidronate—osteoporosis	0.000331	0.00248	CcSEcCtD
Pitavastatin—Diarrhoea—Calcitriol—osteoporosis	0.000331	0.00248	CcSEcCtD
Pitavastatin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00033	0.00248	CcSEcCtD
Pitavastatin—Dizziness—Raloxifene—osteoporosis	0.00033	0.00248	CcSEcCtD
Pitavastatin—Dizziness—Ibandronate—osteoporosis	0.000327	0.00245	CcSEcCtD
Pitavastatin—Rash—Estropipate—osteoporosis	0.000325	0.00244	CcSEcCtD
Pitavastatin—Dermatitis—Estropipate—osteoporosis	0.000324	0.00244	CcSEcCtD
Pitavastatin—Urticaria—Risedronate—osteoporosis	0.000323	0.00243	CcSEcCtD
Pitavastatin—Back pain—Estradiol—osteoporosis	0.000323	0.00242	CcSEcCtD
Pitavastatin—Headache—Estropipate—osteoporosis	0.000323	0.00242	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000322	0.00242	CcSEcCtD
Pitavastatin—Abdominal pain—Risedronate—osteoporosis	0.000322	0.00242	CcSEcCtD
Pitavastatin—Muscle spasms—Estradiol—osteoporosis	0.000321	0.00241	CcSEcCtD
Pitavastatin—Rash—Alendronate—osteoporosis	0.00032	0.0024	CcSEcCtD
Pitavastatin—Insomnia—Zoledronate—osteoporosis	0.00032	0.0024	CcSEcCtD
Pitavastatin—Dermatitis—Alendronate—osteoporosis	0.000319	0.0024	CcSEcCtD
Pitavastatin—Feeling abnormal—Pamidronate—osteoporosis	0.000319	0.00239	CcSEcCtD
Pitavastatin—Headache—Alendronate—osteoporosis	0.000318	0.00239	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000316	0.00238	CcSEcCtD
Pitavastatin—Rash—Raloxifene—osteoporosis	0.000314	0.00236	CcSEcCtD
Pitavastatin—Dermatitis—Raloxifene—osteoporosis	0.000314	0.00236	CcSEcCtD
Pitavastatin—Headache—Raloxifene—osteoporosis	0.000312	0.00235	CcSEcCtD
Pitavastatin—Rash—Ibandronate—osteoporosis	0.000311	0.00234	CcSEcCtD
Pitavastatin—Dermatitis—Ibandronate—osteoporosis	0.000311	0.00234	CcSEcCtD
Pitavastatin—Dyspepsia—Zoledronate—osteoporosis	0.000311	0.00234	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00031	0.00233	CcSEcCtD
Pitavastatin—Ill-defined disorder—Estradiol—osteoporosis	0.00031	0.00232	CcSEcCtD
Pitavastatin—Headache—Ibandronate—osteoporosis	0.000309	0.00232	CcSEcCtD
Pitavastatin—Insomnia—Conjugated Estrogens—osteoporosis	0.000308	0.00231	CcSEcCtD
Pitavastatin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000307	0.00231	CcSEcCtD
Pitavastatin—Nausea—Estropipate—osteoporosis	0.000306	0.0023	CcSEcCtD
Pitavastatin—Abdominal pain—Pamidronate—osteoporosis	0.000306	0.0023	CcSEcCtD
Pitavastatin—Rash—Calcitriol—osteoporosis	0.000305	0.00229	CcSEcCtD
Pitavastatin—Fatigue—Zoledronate—osteoporosis	0.000305	0.00229	CcSEcCtD
Pitavastatin—Dermatitis—Calcitriol—osteoporosis	0.000304	0.00229	CcSEcCtD
Pitavastatin—Headache—Calcitriol—osteoporosis	0.000303	0.00227	CcSEcCtD
Pitavastatin—Constipation—Zoledronate—osteoporosis	0.000302	0.00227	CcSEcCtD
Pitavastatin—Nausea—Alendronate—osteoporosis	0.000301	0.00226	CcSEcCtD
Pitavastatin—Malaise—Estradiol—osteoporosis	0.000301	0.00226	CcSEcCtD
Pitavastatin—Hypersensitivity—Risedronate—osteoporosis	0.0003	0.00225	CcSEcCtD
Pitavastatin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000299	0.00225	CcSEcCtD
Pitavastatin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000299	0.00225	CcSEcCtD
Pitavastatin—Nausea—Raloxifene—osteoporosis	0.000296	0.00222	CcSEcCtD
Pitavastatin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000295	0.00222	CcSEcCtD
Pitavastatin—Fatigue—Conjugated Estrogens—osteoporosis	0.000293	0.0022	CcSEcCtD
Pitavastatin—Nausea—Ibandronate—osteoporosis	0.000293	0.0022	CcSEcCtD
Pitavastatin—Asthenia—Risedronate—osteoporosis	0.000292	0.00219	CcSEcCtD
Pitavastatin—Feeling abnormal—Zoledronate—osteoporosis	0.000291	0.00219	CcSEcCtD
Pitavastatin—Constipation—Conjugated Estrogens—osteoporosis	0.000291	0.00218	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000289	0.00217	CcSEcCtD
Pitavastatin—Pruritus—Risedronate—osteoporosis	0.000288	0.00216	CcSEcCtD
Pitavastatin—Nausea—Calcitriol—osteoporosis	0.000287	0.00216	CcSEcCtD
Pitavastatin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000286	0.00214	CcSEcCtD
Pitavastatin—Hypersensitivity—Pamidronate—osteoporosis	0.000285	0.00214	CcSEcCtD
Pitavastatin—Arthralgia—Estradiol—osteoporosis	0.000284	0.00213	CcSEcCtD
Pitavastatin—Myalgia—Estradiol—osteoporosis	0.000284	0.00213	CcSEcCtD
Pitavastatin—Urticaria—Zoledronate—osteoporosis	0.000281	0.00211	CcSEcCtD
Pitavastatin—Discomfort—Estradiol—osteoporosis	0.000281	0.00211	CcSEcCtD
Pitavastatin—Abdominal pain—Zoledronate—osteoporosis	0.000279	0.0021	CcSEcCtD
Pitavastatin—Diarrhoea—Risedronate—osteoporosis	0.000278	0.00209	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000278	0.00209	CcSEcCtD
Pitavastatin—Asthenia—Pamidronate—osteoporosis	0.000278	0.00208	CcSEcCtD
Pitavastatin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000276	0.00207	CcSEcCtD
Pitavastatin—Confusional state—Estradiol—osteoporosis	0.000275	0.00206	CcSEcCtD
Pitavastatin—Pruritus—Pamidronate—osteoporosis	0.000274	0.00206	CcSEcCtD
Pitavastatin—Urticaria—Conjugated Estrogens—osteoporosis	0.00027	0.00203	CcSEcCtD
Pitavastatin—Dizziness—Risedronate—osteoporosis	0.000269	0.00202	CcSEcCtD
Pitavastatin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000269	0.00202	CcSEcCtD
Pitavastatin—Diarrhoea—Pamidronate—osteoporosis	0.000265	0.00199	CcSEcCtD
Pitavastatin—Rash—Ethinyl Estradiol—osteoporosis	0.000263	0.00198	CcSEcCtD
Pitavastatin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000263	0.00197	CcSEcCtD
Pitavastatin—Headache—Ethinyl Estradiol—osteoporosis	0.000261	0.00196	CcSEcCtD
Pitavastatin—Hypersensitivity—Zoledronate—osteoporosis	0.00026	0.00195	CcSEcCtD
Pitavastatin—Rash—Risedronate—osteoporosis	0.000257	0.00193	CcSEcCtD
Pitavastatin—Dermatitis—Risedronate—osteoporosis	0.000256	0.00192	CcSEcCtD
Pitavastatin—Dizziness—Pamidronate—osteoporosis	0.000256	0.00192	CcSEcCtD
Pitavastatin—Headache—Risedronate—osteoporosis	0.000255	0.00191	CcSEcCtD
Pitavastatin—Asthenia—Zoledronate—osteoporosis	0.000254	0.0019	CcSEcCtD
Pitavastatin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000251	0.00188	CcSEcCtD
Pitavastatin—Pruritus—Zoledronate—osteoporosis	0.00025	0.00188	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000248	0.00186	CcSEcCtD
Pitavastatin—Nausea—Ethinyl Estradiol—osteoporosis	0.000248	0.00186	CcSEcCtD
Pitavastatin—Insomnia—Estradiol—osteoporosis	0.000246	0.00185	CcSEcCtD
Pitavastatin—Asthenia—Conjugated Estrogens—osteoporosis	0.000244	0.00183	CcSEcCtD
Pitavastatin—Rash—Pamidronate—osteoporosis	0.000244	0.00183	CcSEcCtD
Pitavastatin—Dermatitis—Pamidronate—osteoporosis	0.000244	0.00183	CcSEcCtD
Pitavastatin—Headache—Pamidronate—osteoporosis	0.000242	0.00182	CcSEcCtD
Pitavastatin—Diarrhoea—Zoledronate—osteoporosis	0.000242	0.00182	CcSEcCtD
Pitavastatin—Nausea—Risedronate—osteoporosis	0.000242	0.00182	CcSEcCtD
Pitavastatin—Pruritus—Conjugated Estrogens—osteoporosis	0.000241	0.00181	CcSEcCtD
Pitavastatin—Dyspepsia—Estradiol—osteoporosis	0.00024	0.0018	CcSEcCtD
Pitavastatin—Fatigue—Estradiol—osteoporosis	0.000235	0.00176	CcSEcCtD
Pitavastatin—Dizziness—Zoledronate—osteoporosis	0.000234	0.00175	CcSEcCtD
Pitavastatin—Constipation—Estradiol—osteoporosis	0.000233	0.00175	CcSEcCtD
Pitavastatin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000233	0.00175	CcSEcCtD
Pitavastatin—Nausea—Pamidronate—osteoporosis	0.00023	0.00173	CcSEcCtD
Pitavastatin—Dizziness—Conjugated Estrogens—osteoporosis	0.000225	0.00169	CcSEcCtD
Pitavastatin—Feeling abnormal—Estradiol—osteoporosis	0.000224	0.00168	CcSEcCtD
Pitavastatin—Rash—Zoledronate—osteoporosis	0.000223	0.00167	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Estradiol—osteoporosis	0.000223	0.00167	CcSEcCtD
Pitavastatin—Dermatitis—Zoledronate—osteoporosis	0.000223	0.00167	CcSEcCtD
Pitavastatin—Headache—Zoledronate—osteoporosis	0.000221	0.00166	CcSEcCtD
Pitavastatin—Urticaria—Estradiol—osteoporosis	0.000216	0.00162	CcSEcCtD
Pitavastatin—Abdominal pain—Estradiol—osteoporosis	0.000215	0.00162	CcSEcCtD
Pitavastatin—Rash—Conjugated Estrogens—osteoporosis	0.000215	0.00161	CcSEcCtD
Pitavastatin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000214	0.00161	CcSEcCtD
Pitavastatin—Headache—Conjugated Estrogens—osteoporosis	0.000213	0.0016	CcSEcCtD
Pitavastatin—Nausea—Zoledronate—osteoporosis	0.00021	0.00158	CcSEcCtD
Pitavastatin—Nausea—Conjugated Estrogens—osteoporosis	0.000202	0.00152	CcSEcCtD
Pitavastatin—Hypersensitivity—Estradiol—osteoporosis	0.000201	0.00151	CcSEcCtD
Pitavastatin—Asthenia—Estradiol—osteoporosis	0.000195	0.00147	CcSEcCtD
Pitavastatin—Pruritus—Estradiol—osteoporosis	0.000193	0.00145	CcSEcCtD
Pitavastatin—Diarrhoea—Estradiol—osteoporosis	0.000186	0.0014	CcSEcCtD
Pitavastatin—Dizziness—Estradiol—osteoporosis	0.00018	0.00135	CcSEcCtD
Pitavastatin—Rash—Estradiol—osteoporosis	0.000172	0.00129	CcSEcCtD
Pitavastatin—Dermatitis—Estradiol—osteoporosis	0.000172	0.00129	CcSEcCtD
Pitavastatin—Headache—Estradiol—osteoporosis	0.000171	0.00128	CcSEcCtD
Pitavastatin—Nausea—Estradiol—osteoporosis	0.000162	0.00121	CcSEcCtD
Pitavastatin—SLCO1B3—Metabolism—CYP27A1—osteoporosis	4.82e-05	0.000655	CbGpPWpGaD
Pitavastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	4.72e-05	0.000642	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ACP5—osteoporosis	4.69e-05	0.000637	CbGpPWpGaD
Pitavastatin—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	4.65e-05	0.000632	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.63e-05	0.000629	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—TPI1—osteoporosis	4.62e-05	0.000629	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—IDH2—osteoporosis	4.62e-05	0.000629	CbGpPWpGaD
Pitavastatin—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	4.59e-05	0.000624	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PNP—osteoporosis	4.52e-05	0.000615	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ATIC—osteoporosis	4.52e-05	0.000615	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	4.52e-05	0.000614	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TLN1—osteoporosis	4.5e-05	0.000612	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.45e-05	0.000605	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—VCL—osteoporosis	4.44e-05	0.000604	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.42e-05	0.0006	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.36e-05	0.000593	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—TPI1—osteoporosis	4.36e-05	0.000593	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—P4HB—osteoporosis	4.35e-05	0.000591	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CYP27A1—osteoporosis	4.35e-05	0.000591	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	4.33e-05	0.000589	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GAPDH—osteoporosis	4.27e-05	0.00058	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.25e-05	0.000578	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ACP5—osteoporosis	4.23e-05	0.000575	CbGpPWpGaD
Pitavastatin—ABCC2—NRF2 pathway—TGFB1—osteoporosis	4.18e-05	0.000569	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.18e-05	0.000568	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—RAP1A—osteoporosis	4.16e-05	0.000565	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—OXCT1—osteoporosis	4.16e-05	0.000565	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CA2—osteoporosis	4.16e-05	0.000565	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.15e-05	0.000565	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—IL1B—osteoporosis	4.14e-05	0.000563	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—ENO1—osteoporosis	4.12e-05	0.00056	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—P4HB—osteoporosis	4.1e-05	0.000557	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PSMA5—osteoporosis	4.06e-05	0.000552	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PSMA2—osteoporosis	4.06e-05	0.000552	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—MGLL—osteoporosis	4.05e-05	0.000551	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—CYP19A1—osteoporosis	4.04e-05	0.00055	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GAPDH—osteoporosis	4.02e-05	0.000547	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.96e-05	0.000538	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—TNF—osteoporosis	3.96e-05	0.000538	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—TPI1—osteoporosis	3.93e-05	0.000535	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	3.92e-05	0.000534	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—RAP1A—osteoporosis	3.92e-05	0.000533	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CA2—osteoporosis	3.85e-05	0.000523	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—OXCT1—osteoporosis	3.85e-05	0.000523	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.82e-05	0.000519	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—MGLL—osteoporosis	3.75e-05	0.00051	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—RAP1A—osteoporosis	3.71e-05	0.000504	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—P4HB—osteoporosis	3.7e-05	0.000503	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—TGFB1—osteoporosis	3.63e-05	0.000494	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GAPDH—osteoporosis	3.63e-05	0.000493	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.55e-05	0.000483	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—RAP1A—osteoporosis	3.53e-05	0.000481	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.53e-05	0.00048	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	3.46e-05	0.000471	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—IDH2—osteoporosis	3.44e-05	0.000468	CbGpPWpGaD
Pitavastatin—CYP2C8—Biological oxidations—POMC—osteoporosis	3.43e-05	0.000467	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.42e-05	0.000465	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.4e-05	0.000462	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—FGA—osteoporosis	3.36e-05	0.000457	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ENO1—osteoporosis	3.36e-05	0.000457	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PSMA2—osteoporosis	3.31e-05	0.00045	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PSMA5—osteoporosis	3.31e-05	0.00045	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—ADCY5—osteoporosis	3.3e-05	0.000449	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—CYP19A1—osteoporosis	3.29e-05	0.000448	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—GPX1—osteoporosis	3.29e-05	0.000448	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—FDPS—osteoporosis	3.24e-05	0.00044	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PKM—osteoporosis	3.24e-05	0.00044	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CYP27A1—osteoporosis	3.24e-05	0.00044	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PKM—osteoporosis	3.22e-05	0.000438	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—FDPS—osteoporosis	3.22e-05	0.000438	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—TGFB1—osteoporosis	3.21e-05	0.000437	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—IL6—osteoporosis	3.19e-05	0.000434	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—IDH2—osteoporosis	3.19e-05	0.000434	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ENO1—osteoporosis	3.17e-05	0.000431	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.16e-05	0.00043	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ACP5—osteoporosis	3.15e-05	0.000428	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—TNF—osteoporosis	3.14e-05	0.000427	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PSMA2—osteoporosis	3.12e-05	0.000424	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PSMA5—osteoporosis	3.12e-05	0.000424	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.11e-05	0.000423	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PGLS—osteoporosis	3.07e-05	0.000418	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GPD2—osteoporosis	3.07e-05	0.000418	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—FGB—osteoporosis	3.06e-05	0.000416	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	3.06e-05	0.000416	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PGLS—osteoporosis	3.05e-05	0.000415	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GPD2—osteoporosis	3.05e-05	0.000415	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—MTHFR—osteoporosis	3.04e-05	0.000413	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—TNF—osteoporosis	3e-05	0.000408	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP27A1—osteoporosis	3e-05	0.000408	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.97e-05	0.000403	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—TPI1—osteoporosis	2.93e-05	0.000398	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ACP5—osteoporosis	2.92e-05	0.000397	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.89e-05	0.000393	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ENO1—osteoporosis	2.86e-05	0.000389	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PKM—osteoporosis	2.82e-05	0.000384	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—FDPS—osteoporosis	2.82e-05	0.000384	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PSMA2—osteoporosis	2.81e-05	0.000383	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PSMA5—osteoporosis	2.81e-05	0.000383	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ATIC—osteoporosis	2.81e-05	0.000382	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PNP—osteoporosis	2.81e-05	0.000382	CbGpPWpGaD
Pitavastatin—CYP2C9—Biological oxidations—POMC—osteoporosis	2.79e-05	0.00038	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ATIC—osteoporosis	2.79e-05	0.00038	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PNP—osteoporosis	2.79e-05	0.00038	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—P4HB—osteoporosis	2.75e-05	0.000374	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.75e-05	0.000374	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—TPI1—osteoporosis	2.71e-05	0.000369	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GAPDH—osteoporosis	2.7e-05	0.000367	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—ADCY5—osteoporosis	2.69e-05	0.000366	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	2.69e-05	0.000366	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CYP19A1—osteoporosis	2.69e-05	0.000365	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—GPX1—osteoporosis	2.68e-05	0.000365	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PGLS—osteoporosis	2.67e-05	0.000364	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GPD2—osteoporosis	2.67e-05	0.000364	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	2.65e-05	0.00036	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—FDPS—osteoporosis	2.64e-05	0.000358	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PKM—osteoporosis	2.64e-05	0.000358	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—RAP1A—osteoporosis	2.63e-05	0.000358	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—P4HB—osteoporosis	2.55e-05	0.000347	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—IL6—osteoporosis	2.54e-05	0.000345	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CYP19A1—osteoporosis	2.53e-05	0.000344	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GAPDH—osteoporosis	2.5e-05	0.00034	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PGLS—osteoporosis	2.5e-05	0.00034	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GPD2—osteoporosis	2.5e-05	0.00034	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—MTHFR—osteoporosis	2.48e-05	0.000337	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ATIC—osteoporosis	2.45e-05	0.000333	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PNP—osteoporosis	2.45e-05	0.000333	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—RAP1A—osteoporosis	2.44e-05	0.000331	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—POMC—osteoporosis	2.43e-05	0.00033	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CA2—osteoporosis	2.39e-05	0.000325	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—OXCT1—osteoporosis	2.39e-05	0.000325	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CA2—osteoporosis	2.37e-05	0.000323	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—OXCT1—osteoporosis	2.37e-05	0.000323	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—MGLL—osteoporosis	2.33e-05	0.000316	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—MGLL—osteoporosis	2.31e-05	0.000315	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.29e-05	0.000312	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ATIC—osteoporosis	2.29e-05	0.000311	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PNP—osteoporosis	2.29e-05	0.000311	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CYP19A1—osteoporosis	2.28e-05	0.000311	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ADCY5—osteoporosis	2.19e-05	0.000298	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.19e-05	0.000298	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GPX1—osteoporosis	2.19e-05	0.000297	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.18e-05	0.000297	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ENO1—osteoporosis	2.13e-05	0.000289	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PSMA2—osteoporosis	2.1e-05	0.000285	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PSMA5—osteoporosis	2.1e-05	0.000285	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CA2—osteoporosis	2.08e-05	0.000283	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—OXCT1—osteoporosis	2.08e-05	0.000283	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ADCY5—osteoporosis	2.07e-05	0.000281	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GPX1—osteoporosis	2.06e-05	0.00028	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—MGLL—osteoporosis	2.03e-05	0.000276	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—MTHFR—osteoporosis	2.02e-05	0.000274	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—POMC—osteoporosis	1.98e-05	0.000269	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—IDH2—osteoporosis	1.98e-05	0.000269	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ENO1—osteoporosis	1.97e-05	0.000268	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—IDH2—osteoporosis	1.97e-05	0.000268	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—OXCT1—osteoporosis	1.94e-05	0.000264	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CA2—osteoporosis	1.94e-05	0.000264	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PSMA2—osteoporosis	1.94e-05	0.000264	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PSMA5—osteoporosis	1.94e-05	0.000264	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—MTHFR—osteoporosis	1.9e-05	0.000259	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—MGLL—osteoporosis	1.89e-05	0.000258	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ADCY5—osteoporosis	1.87e-05	0.000254	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP27A1—osteoporosis	1.86e-05	0.000253	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GPX1—osteoporosis	1.86e-05	0.000253	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP27A1—osteoporosis	1.85e-05	0.000252	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ACP5—osteoporosis	1.81e-05	0.000246	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ACP5—osteoporosis	1.8e-05	0.000245	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.79e-05	0.000243	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.79e-05	0.000243	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.78e-05	0.000242	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—IDH2—osteoporosis	1.72e-05	0.000234	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—MTHFR—osteoporosis	1.72e-05	0.000233	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CYP19A1—osteoporosis	1.7e-05	0.000231	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.69e-05	0.000231	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—TPI1—osteoporosis	1.68e-05	0.000229	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—TPI1—osteoporosis	1.67e-05	0.000227	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP27A1—osteoporosis	1.62e-05	0.00022	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—POMC—osteoporosis	1.61e-05	0.00022	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.61e-05	0.000219	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—IDH2—osteoporosis	1.61e-05	0.000219	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.59e-05	0.000216	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.59e-05	0.000216	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—P4HB—osteoporosis	1.58e-05	0.000215	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ACP5—osteoporosis	1.58e-05	0.000214	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP19A1—osteoporosis	1.57e-05	0.000214	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—P4HB—osteoporosis	1.57e-05	0.000214	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GAPDH—osteoporosis	1.55e-05	0.000211	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GAPDH—osteoporosis	1.54e-05	0.00021	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—POMC—osteoporosis	1.52e-05	0.000207	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.51e-05	0.000206	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—RAP1A—osteoporosis	1.51e-05	0.000206	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—RAP1A—osteoporosis	1.5e-05	0.000204	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.49e-05	0.000202	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.48e-05	0.000201	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ACP5—osteoporosis	1.47e-05	0.0002	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—TPI1—osteoporosis	1.47e-05	0.000199	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.45e-05	0.000198	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ADCY5—osteoporosis	1.39e-05	0.000189	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IGF1—osteoporosis	1.39e-05	0.000188	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GPX1—osteoporosis	1.38e-05	0.000188	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—P4HB—osteoporosis	1.38e-05	0.000187	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—POMC—osteoporosis	1.37e-05	0.000187	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—TPI1—osteoporosis	1.37e-05	0.000186	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GAPDH—osteoporosis	1.35e-05	0.000184	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.32e-05	0.000179	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—RAP1A—osteoporosis	1.32e-05	0.000179	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.31e-05	0.000178	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—P4HB—osteoporosis	1.29e-05	0.000175	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ADCY5—osteoporosis	1.29e-05	0.000175	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GPX1—osteoporosis	1.28e-05	0.000174	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—MTHFR—osteoporosis	1.28e-05	0.000174	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GAPDH—osteoporosis	1.26e-05	0.000172	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—RAP1A—osteoporosis	1.23e-05	0.000167	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ENO1—osteoporosis	1.22e-05	0.000166	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ENO1—osteoporosis	1.22e-05	0.000165	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PSMA2—osteoporosis	1.2e-05	0.000164	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PSMA5—osteoporosis	1.2e-05	0.000164	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PSMA5—osteoporosis	1.2e-05	0.000163	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PSMA2—osteoporosis	1.2e-05	0.000163	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—MTHFR—osteoporosis	1.18e-05	0.000161	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.07e-05	0.000146	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ENO1—osteoporosis	1.06e-05	0.000145	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PSMA2—osteoporosis	1.05e-05	0.000143	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PSMA5—osteoporosis	1.05e-05	0.000143	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—POMC—osteoporosis	1.02e-05	0.000139	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ENO1—osteoporosis	9.95e-06	0.000135	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PSMA5—osteoporosis	9.8e-06	0.000133	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PSMA2—osteoporosis	9.8e-06	0.000133	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP19A1—osteoporosis	9.77e-06	0.000133	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP19A1—osteoporosis	9.72e-06	0.000132	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—POMC—osteoporosis	9.46e-06	0.000129	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP19A1—osteoporosis	8.51e-06	0.000116	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TGFB1—osteoporosis	8.3e-06	0.000113	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ADCY5—osteoporosis	7.98e-06	0.000109	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GPX1—osteoporosis	7.96e-06	0.000108	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP19A1—osteoporosis	7.95e-06	0.000108	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ADCY5—osteoporosis	7.94e-06	0.000108	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GPX1—osteoporosis	7.91e-06	0.000108	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—MTHFR—osteoporosis	7.34e-06	9.99e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—MTHFR—osteoporosis	7.3e-06	9.93e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ADCY5—osteoporosis	6.96e-06	9.46e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GPX1—osteoporosis	6.93e-06	9.43e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ADCY5—osteoporosis	6.5e-06	8.84e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GPX1—osteoporosis	6.48e-06	8.81e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—MTHFR—osteoporosis	6.4e-06	8.7e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—MTHFR—osteoporosis	5.98e-06	8.13e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—POMC—osteoporosis	5.87e-06	7.99e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—POMC—osteoporosis	5.84e-06	7.94e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—POMC—osteoporosis	5.12e-06	6.96e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—POMC—osteoporosis	4.78e-06	6.5e-05	CbGpPWpGaD
